Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases

JAMA Neurology · Published 2026-03-09 · DOI 10.1001/jamaneurol.2026.0240

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1001/jamaneurol.2026.0240

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Multiple Sclerosis Onset Preceding Epstein-Barr Virus Infection · JAMA Neurology · 2026 · Cites or is cited by this article · Same journal
• Neurological Manifestations in Adult Survivors of Ebola Virus Disease · JAMA Neurology · 2026 · Same journal
• Musical Trick Alleviating Benign Essential Blepharospasm · JAMA Neurology · 2026 · Same journal
• Comorbidities and Outcomes in People With Functional Neurological Disorder · JAMA Neurology · 2026 · Same journal
• Neurological Teleconsultations in General Practice · JAMA Neurology · 2026 · Same journal
• Complete Remission of Cavin-4 Immunoglobulin G Rippling Muscle Disease After Rituximab Therapy · JAMA Neurology · 2026 · Same journal
• Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis · JAMA Neurology · 2026 · Same journal
• Pathology and Genetics in a Global Cohort of Parkinsonian Disorders · JAMA Neurology · 2026 · Same journal
• Neurological Manifestations of Hantavirus Infection · JAMA Neurology · 2026 · Same journal
• Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer Disease · JAMA Neurology · 2026 · Same journal